Cornea Research Foundation of America

04/24/2026

04/13/2026

Good news -- adverse events are steadily declining, along with cases of infectious keratitis and primary graft failure.

The News Feed Published April 9, 2026 • By Staff Cornea, News Corneal Donor Tissue Quality Has Increased Adverse events are steadily declining, along with cases of infectious keratitis and primary graft failure. Between 2007 and 2024, there was a shift toward pre-cut corneal tissue in the United S...

04/01/2026

April is National Donate Life Month! This year’s theme uses trees as a symbol of life and connection. Just like trees grow and support each other in a forest, donation connects people – donors, recipients, and their families. Like a tree that grows and stands for generations, a donor’s gift leaves a lasting legacy of hope and life. 🌳
This National Donate Life Month, join us in helping to save and heal lives – register your decision to be an organ, eye and tissue donor at RegisterMe.org and share your decision with your family and community! 💙💚 Visit www.DonateLife.net/NDLM for free resources you can share!

03/20/2026

Current research on dry eye and IPL treatment: https://pubmed.ncbi.nlm.nih.gov/?term=%28intense+pulsed+light%29+AND+%28dry+eye%29&sort=date

03/18/2026

Dr. Price discusses the latest in neurotrophic keratitis (NK) in this video. NK is a rare and degenerative eye disease caused by impaired corneal nerves. Patients lose sensation in the cornea which can damage vision if you don't blink or produce tears enough and can lead to wounds on the surface of the eye.

WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, Francis W. Price Jr., MD, of Price Vision Group, discusses the latest in neurotrophic keratitis.Price said pharmaceuticals are under study for neurotrophic keratitis, nonhealing epithelial defects and limbal stem cell defici...

03/16/2026

Because of our incredible community, vision research continues to move forward. If you haven't already, be sure to review our recent impact report: https://tinyurl.com/corneareport

03/16/2026

03/16/2026

March is Women's History Month. EBAA and eye banking and cornea transplantation is lucky to be filled with impressive, trailblazing women.

One such woman is Marianne Price Ph.D., of the Cornea Research Foundation of America. The first woman (and Valedictorian) to graduate from the University of Notre Dame with an engineering degree, she is also a mother of four, member of the American Academy of Ophthalmology, on the Editorial Board of Cornea, and the recipient of EBAA's 2025 R. Townley Paton Award - the association's highest honor for physicians.

For more on Marianne and other women in eye banking, see our website:
https://restoresight.org/news/womens-history-at-ebaa/

03/11/2026

https://www.medscape.com/viewarticle/vitamin-d-deficiency-linked-dry-eye-disease-2026a10006v7?ecd=mkm_CS_260309_mscpmrk-CS_CuAr_pos1_etid8168524&uac=438161HR&impID=8168524

Adults with a deficiency of vitamin D are at increased risk for developing dry eye disease than those without low levels of the nutrient, a study finds.

03/05/2026

Peter’s Anomaly is a rare congenital eye disorder present at birth that causes central corneal clouding.

In severe cases, the cornea does not fully develop, leading to significant vision loss early in life. Some children may require a corneal transplant in infancy or early childhood to give them the best chance at vision.

Because it’s rare, families often feel isolated — but research, early diagnosis, and surgical advances are improving outcomes every year.

03/05/2026

https://www.healio.com/news/ophthalmology/20260304/photobiomodulation-revolutionary-breakthrough-or-scam

Photobiomodulation with the Valeda light delivery system was authorized in November 2024, and we have been treating patients with it since summer 2025.It seems too simple to be true that we could shine a light in someone’s eyes for a few minutes nine times every 4 months and that it would help...

02/28/2026

Today is Rare Disease Day. This week we will highlight a few rare conditions that can result in the need for a cornea transplant.

ICE (Iridocorneal Endothelial) syndrome is a rare eye condition that usually shows up in adults ages 20–50, and more often in women. Some patients may eventually need a cornea transplant.

Common symptoms can include:
• Blurry or hazy vision (from corneal swelling)
• Light sensitivity
• Changes in pupil shape
• Eye pressure that can lead to glaucoma

Learn more from the American Academy of Ophthalmology:
👉 https://www.aao.org/eye-health/diseases/iridocorneal-endothelial-syndrome-ice e

Iridocorneal endothelial syndrome (ICE) is a rare eye condition affecting corneal cells and the iris. Because ICE can lead to glaucoma, treatment is focused on managing the glaucoma.